10 Results for "

human P2X2

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "human P2X2" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-108676
CAS No.: 104869-31-0
Purity:  99.99%
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

NF023 hexasodium is a selective and competitive P2X1 receptor antagonist, with IC50 values of 0.21 μM, 28.9 μM, > 50 μM and > 100 μM for human P2X1, P2X3, P2X2, and P2X4-mediated responses respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14483
CAS No.: 865305-30-2
Purity:  99.53%
Synonyms: Ro-4
Target:  

P2X Receptor

Research Areas:  

Cancer

AF-353 (Ro-4) is a potent, selective and orally bioavailable P2X3/P2X2/3 receptor antagonist, with a pIC50 of 8.0 for both human and rat P2X3, and with a pIC50 of 7.3 for human P2X2/3 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1441A
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Mambalgin 1 TFA is a selective ASIC1a inhibitor (IC50 values are 192 and 72 nM for human ASIC1a and ASIC1a/1b dimer, respectively). Mambalgin 1 TFA binds to closed/inactive channel. Mambalgin 1 TFA is selective for ASIC1a over ASIC2a, ASIC3, TRPV1, P2X2, 5-HT3, Nav1.8, Cav3.2 and Kv1.2 channels. Mambalgin 1 TFA increases latency of withdrawal response in mouse tail-flick and paw-flick tests.
loading...
    loading...
Cat. No.: HY-135976
CAS No.: 2417288-67-4
Purity:  99.71%
P2X3 antagonist 34 is a potent, selective and orally active P2X3 homotrimeric receptor antagonist with IC50s of 25 nM, 92 nM and 126 nM for human P2X3, rat P2X3 and guinea pig P2X3 receptors, respectively. P2X3 antagonist 34 is less active against human, rat and guinea pig P2X2/3 heterotrimeric receptors. P2X3 antagonist 34 has strong anti-tussive effect .
loading...
    loading...
Cat. No.: HY-19978
CAS No.: 1026582-88-6
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

RO-3 is a potent, and orally active P2X3 and P2X2/3 antagonist with pIC50s of 5.9 and 7.0 for human homomultimeric P2X3 and heteromultimeric P2X2/3 receptors, respectively. RO-3 shows selectivity for P2X3 and P2X2/3 over all other functional homomultimeric P2X receptors (IC50 >10 μM at P2X1,2,4,5,7) .
loading...
    loading...
Cat. No.: HY-137610A
Research Areas:  

Neurological Disease

TNP-ATP is an antagonist of purinergic P2Y1, P2X3, and P2X2/3 receptors (IC50 = 6, 0.9, and 7 nM, respectively, in HEK293 cells expressing human receptors). TNP-ATP reduces acetate-induced calcium flux in 1321N1 cells expressing P2X3 and P2X2/3 receptors (IC50 = 100 and 62 nM, respectively). TNP-ATP dose-dependently attenuates acetate-induced abdominal contractions in a mouse visceral pain model (ED50 = 6.35 µmol/kg) [1][2].
loading...
    loading...
Cat. No.: HY-14483A
CAS No.: 927887-18-1
Synonyms: Ro-4 hydrochloride
Target:  

P2X Receptor

Research Areas:  

Cancer

AF-353 hydrochloride is a potent, selective and orally bioavailable P2X3/P2X2/3 receptor antagonist, with a pIC50 of 8.0 for both human and rat P2X3, and with a pIC50 of 7.3 for human P2X2/3 .
loading...
    loading...
Cat. No.: HY-14483R
CAS No.: 865305-30-2
Synonyms: Ro-4 (Standard)
Research Areas:  

Cancer

AF-353 (Standard) is the analytical standard of AF-353. This product is intended for research and analytical applications. AF-353 (Ro-4) is a potent, selective and orally bioavailable P2X3/P2X2/3 receptor antagonist, with a pIC50 of 8.0 for both human and rat P2X3, and with a pIC50 of 7.3 for human P2X2/3 .
loading...
    loading...
Cat. No.: HY-186112
CAS No.: 88134-39-8
Target:  

P2X Receptor

Research Areas:  

Inflammation/Immunology

PSFL2915 is a selective, orally active P2X receptor inhibitor with oral effectiveness, with an IC50 of 0.319 μM for human P2X3, 0.261 μM for rat P2X2/3, and 13.3 μM for human P2X2. PSFL2915 exhibits ~42-fold selectivity over human P2X2. PSFL2915 can be used for the research of chronic cough .
loading...
    loading...
Cat. No.: HY-182715
CAS No.: 66295-57-6
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

PSB-10211 is a P2X2 receptor antagonist with an IC50 of 0.086 μM against rat P2X2 receptors. PSB-10211 inhibits ATP-mediated currents of rat P2X2 receptors expressed in Xenopus oocytes. PSB-10211 can be used in studies related to pain and urinary incontinence .
loading...
    loading...